Companies › Harbour Antibodies

Harbour Antibodies

Healthcare 📍 Cambridge, United States 👥 11-50 employees 💰 $3.2M raised 📅 Founded 2006

Harbour Antibodies BV was established in 2006 to use transgenic mouse technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands) for engineering mice to produce high affinity human antibodies. The company has developed two types of human immunoglobulin gene transgenic

📊 Company Overview

Sector
Healthcare
Country
United States
Employees
11-50
Total Raised · Venture
$3.2M
Founded
2006
Cloud
Unknown
Email
Microsoft 365

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider
WorkspaceMicrosoft 365
CDN🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / Platform🔒 Subscribers only
Frontend Stack🔒 Subscribers only

Detected from Harbour Antibodies's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction